The McQuade Center for Strategic Research and Development and Mindset Pharma...

Awakn Life Sciences Announces Voluntary Lock-up Agreement Extension with Management, Board...

PT281 – Oliver Grundmann, Ph.D. – A Thorough Exploration of Kratom

MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC

COMP360 psilocybin study of 89 healthy participants published in Journal of...

MHRA Guidance on the use of Real-World Data in Clinical Studies...

Psychedelic Bulletin: First Look at Field Trip’s FT-104 Molecule; MindMed Trial...

PT280 – Danny Peterson ​​– Psychedelics, Religion, and Freedom

Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge...

MindMed Announces Transitions to Management Team

Load more